TrialBritish journal of cancer2002

Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer.

P A Vasey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.